phase II Vs phase I, page-39

You can only imagine the companies that do have massive Market Caps who are in the same space as LCT. If I were a shareholder in one of those @$23 a share and LCT release they have the treatment for Parkinsons you can only imagine the funds shifting toward LCT. Plus an endorsement from M J Fox or Billy Connolly and a good editorial piece on CNBC , BBC, China TV. Plus there are Medical based Managed Funds in the States and Europe, they by mandate may need a % or 3 in LCT from their Investors. We have had the benefit of small Domestic Investment Houses, Milford etc but I'm talking Funds in the Billions that will need a position in LCT or Investors move to a Fund that does include LCT...